Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

MYLAN TECHNOLOGIES

  • FDA Approval
  • Jan. 23, 2025, 09:43 UTC
  • 77
  • 0 comments

FDA approve RIVASTIGMINE

Comment Full text

INNOGENIX

  • FDA Approval
  • Jan. 23, 2025, 09:43 UTC
  • 72
  • 0 comments

FDA approve HALOPERIDOL

Comment Full text

AMNEAL PHARMS

  • FDA Approval
  • Jan. 23, 2025, 09:43 UTC
  • 71
  • 0 comments

FDA approve RIVASTIGMINE

Comment Full text

COSETTE

  • FDA Approval
  • Jan. 23, 2025, 09:43 UTC
  • 68
  • 0 comments

FDA approve PROCHLORPERAZINE

Comment Full text

ACADIA PHARMS INC

  • FDA Approval
  • Jan. 23, 2025, 09:43 UTC
  • 68
  • 0 comments

FDA approve PIMAVANSERIN TARTRATE

Comment Full text

NORVIUM BIOSCIENCE

  • FDA Approval
  • Jan. 23, 2025, 09:43 UTC
  • 72
  • 0 comments

FDA approve PROCHLORPERAZINE MALEATE

Comment Full text

HIKMA

  • FDA Approval
  • Jan. 23, 2025, 09:43 UTC
  • 63
  • 0 comments

FDA approve ERTUGLIFLOZIN

Comment Full text

ANNORA PHARMA

  • FDA Approval
  • Jan. 23, 2025, 09:43 UTC
  • 55
  • 0 comments

FDA approve DARUNAVIR

Comment Full text

KYOWA KIRIN

  • FDA Approval
  • Jan. 23, 2025, 09:43 UTC
  • 51
  • 0 comments

FDA approve MOGAMULIZUMAB-KPKC

Comment Full text

LGM PHARMA

  • FDA Approval
  • Jan. 23, 2025, 09:43 UTC
  • 65
  • 0 comments

FDA approve ASPIRIN; BUTALBITAL; CAFFEINE

Comment Full text
  • Previous
  • 246
  • 247
  • 248
  • 249
  • 250
  • Next

Search

News categories

  • Technical Exchange News(11417)
  • Event(3074)
  • SEC News(209366)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(135802)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin